L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea · Delayed Price · Currency is KRW 53,700
-2,600 (-4.62%)
Oct 2, 2026, 3:30 PM KST
L&C BIO Co.,LTD Market Cap
L&C BIO Co.,LTD has a market cap or net worth of 1.45 trillion as of October 1, 2026. Its market cap has increased by 15.80% in one year.
Market Cap
1.45T
Enterprise Value
1.48T
Revenue
116.30B
Ranking
n/a
PE Ratio
n/a
Stock Price
53,700.00
ChartMarket Cap Chart
Since November 1, 2018, L&C BIO Co.,LTD's market cap has increased from 194.97B to 1.45T, an increase of 642.84%. That is a compound annual growth rate of 28.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.45T | -3.72% |
| Dec 30, 2025 | 1.50T | 175.14% |
| Dec 30, 2024 | 546.71B | -16.90% |
| Dec 28, 2023 | 657.86B | 25.54% |
| Dec 29, 2022 | 524.02B | -36.89% |
| Dec 30, 2021 | 830.27B | 10.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 1, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CLASSYS | 1.97T |
| Seegene | 1.62T |
| SEERS | 976.23B |
| SD Biosensor | 733.27B |
| InBody Co.,Ltd | 702.03B |
| BioNote | 471.77B |
| i-SENS | 454.64B |
| T&L Co., Ltd. | 441.59B |